While it has been established that Plexin-A4 plays a role in inhibiting tumor angiogenesis through Sema3A signaling, it is important to note that there is a need for additional research in the context of vascularization-mediated bone regeneration (Kigel et al., 2011). This evidence concerns the gene SEMA3A and neoplasm.